Staff Reporter Islamabad
The antimicrobial or antibiotic resistance (AMR) has increased the risk of human deaths to reach 10 million per year by 2050 across the world due to declining efficiency of various modern medications curing infectious diseases caused by bacteria, viruses and fungi.
The UK’s Fleming Fund has initiated a stakeholder intervention in Pakistan to scale up public healthcare setup of Pakistan to enhance effective monitoring and data collection to curb the impending risk of antimicrobial or antibiotic resistance (AMR) causing serious health complications leading to death.
Country Director Fleming Fund Dr Ayesha told APP that non-prescribed and excessive use of antibiotics in infectious diseases, epidemics and other health issues was causing the emergence of resistant bugs making many of the modern diseases ineffective.
